Gilde Healthcare Services invests in nursing homes - Gilde Healthcare

Gilde Healthcare Services invests in nursing homes

24 oktober 2010

Utrecht, The Netherlands – Gilde Healthcare Services (Gilde), a growth capital fund specialised in Healthcare Services, has acquired a significant minority stake in elderly care provider Stepping Stones Home & Care (Stepping Stones) of the Netherlands to fund further growth of the company.

Stepping Stones operates a chain of nursing homes providing care for elderly with Alzheimer’s disease and related conditions that need continuous support. The nursing homes offer a safe, protected and continuous care environment with affordable services tailored to the needs of residents (www.steppingstonesbv.nl).

Stepping Stones founding managers Arthur Scherpenzeel and Christiaan Sap commented:

“We are thrilled with the investment from Gilde. This investment not only enables us to expand the number of locations but we will also benefit from Gilde’s hands-on approach and healthcare expertise.

Jasper van Gorp, Partner of the Gilde Healthcare Services fund said:

“We were impressed by Stepping Stones’ ability to provide a very high quality yet affordable care home service. We believe that there is a considerable need for this type of service which can co-exist alongside care provided by the public sector in the Netherlands. This investment is aligned perfectly with our investment focus on high growth healthcare services companies.

Meer nieuws

Gilde Healthcare lanceert Climate Solutions fonds en haalt €250 mln op

Met commitments van internationale pensioenfondsen, banken, fund-of-funds, endowments en family offices realiseert Gilde Healthcare een eerste closing van €250 miljoen Uitbreiding naar Climate Solutions bouwt voort op Gilde Healthcare’s track-record in impactvol investeren en rapportage...
18 februari 2026

Gilde Healthcare Company Big Health Secures Funding to Accelerate Adoption of Digital Mental Health Treatments

New investment fuels expansion as leading health systems adopt evidence-based digital care, driven by new billing codes and strong demand for proven mental health solutions. Big Health, a leading developer of digital treatments for the...
12 februari 2026

Gilde Healthcare company SpyGlass Pharma announces pricing of initial public offering at NASDAQ

SpyGlass Pharma, Inc. (Nasdaq: SGP) (“SpyGlass Pharma”), a late-stage biopharmaceutical company, today announced the pricing of its initial public offering of 9,375,000 shares of its common stock at a public offering price of $16.00 per...
6 februari 2026